top
Search terms
Results 1 - 10 of 14 - ordered by :
Pages: 1 2
Escardio

Stable all-comer coronary artery disease (CAD) patients referred for coronary angiography with at least two-vessel disease including the left anterior descending coronary artery, left main coronary ...

Date : 29/08/2018
Escardio

Today, a team led by Professor Maciej Banach (Medical University of Lodz, Poland) will present the findings of an analysis into the long-term impact of low-carbohydrate diets on mortality (Abstract ...

Date : 28/08/2018
Escardio

“Contrary to what has been believed for decades,” says Dr. Mente, “the Prospective Urban Rural Epidemiology (PURE) study revealed that a high-carbohydrate diet increases the risk of ...

Date : 29/08/2018
Escardio

The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk, according to late-breaking results from the ARRIVE study1 ...

Date : 26/08/2018
Escardio

(1) Professor Keith Fox, principal investigator, University of Edinburgh, UK, said: “These findings challenge the use of combined oral anticoagulant and antiplatelet therapy in patients with ...

Date : 28/08/2018
Escardio

Median follow-up was 60 months and the primary endpoint was time to first occurrence of a composite of cardiovascular death, myocardial infarction (MI), stroke, unstable angina and transient ...

Date : 27/08/2018
Escardio

Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study published today in the ...

Date : 17/01/2018
Escardio

Clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) has progressively improved within the last two decades, in part because of faster diagnosis with invasive ...

Date : 28/08/2018
Escardio

The foods that make up a heart healthy diet for people worldwide may differ from what was previously thought, according to late breaking results from the observational Prospective Urban Rural ...

Date : 28/08/2018
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018